Iobenguane I 131 (original) (raw)

This page contains brief information about iobenguane I 131 and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

FDA label information for this drug is available at DailyMed.

Use in Cancer

Iobenguane I 131 is approved to treat:

• Pheochromocytoma or paraganglioma that is malignant and requires systemic anticancer therapy. It is used in adults and children aged 12 years or older whose iobenguane scan was positive and whose disease is locally advanced, has spread to other parts of the body, or cannot be removed by surgery.

Iobenguane I 131 is also being studied in the treatment of other types ofcancer.

More About Iobenguane I 131

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Iobenguane I-131 - Check for trials from NCI's list of cancer clinical trials now accepting patients.